Merck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase – Here’s Why

Merck KGaA (OTCMKTS:MKGAF) saw unusually-strong trading volume on Tuesday . 686 shares traded hands during mid-day trading, an increase of 10% from the previous session’s volume of 621 shares.The stock last traded at $162.55 and had previously closed at $158.25.

Merck KGaA Stock Performance

The company has a 50-day moving average price of $162.50 and a two-hundred day moving average price of $148.28. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $21.63 billion, a P/E ratio of 25.55 and a beta of 0.96.

Hedge Funds Weigh In On Merck KGaA

A number of institutional investors have recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC bought a new position in shares of Merck KGaA in the second quarter worth approximately $25,000. Rakuten Securities Inc. bought a new position in shares of Merck KGaA during the 2nd quarter valued at $27,000. Solstein Capital LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at $33,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA in the 2nd quarter worth $33,000. Finally, Burk Holdings LLC purchased a new position in Merck KGaA in the 2nd quarter worth $39,000. 0.10% of the stock is currently owned by institutional investors.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.